Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmiva AB (publ)
Lund, Sweden
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
01
Overview
Pharmiva developed Vernivia, a CE-marked, antibiotic-free vaginal mousse based on its proprietary Venerol platform. Vernivia has been launched commercially in Sweden as an over-the-counter treatment for bacterial vaginosis. The company holds patents on its delivery technology and plans to expand into additional women’s health indications such as yeast infections and STD prevention. Clinical results support efficacy in treating bacterial vaginosis without antibiotics.
- Therapeutic areas
- Women's HealthInfectious Diseases
- Modalities
- Topical medical device/moussenon-antibiotic therapy
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on Pharmiva AB (publ).
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharmiva AB (publ).